Maged Wasfy Helmy

12PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersToxicology (incl. clinical toxicology)Electrochemical energy storage and conversionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
From Design to Synergy: Triazine-Triazole Hybrids as Anti-Breast Cancer Leads Targeting Survival and Invasion Pathways for Augmenting Lapatinib Efficacy.

|Jun 16, 2026
Enhanced antitumor efficacy of sulfasalazine and mesalazine in colorectal cancer through modulatory action of Lacticaseibacillus rhamnosus GG.

|Apr 16, 2026
Anti-arthritic efficacy of geraniol and methotrexate via miRNA-driven NLRP3 inflammasome suppression in rat adjuvant-induced arthritis.

|Feb 17, 2026
Sulfasalazine mitigates cisplatin-induced nephrotoxicity via NF-κB downregulation and upstream modulation of p-AMPK, SIRT1, miRNA-132-3p, and miRNA-375.

Mohammed G Hassan, Ihab T Abdel-Raheem, Asser I Ghoneim

|Nov 06, 2024
Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations.

Maged W Helmy, Mariam H Youssef, Imane Yamari

|Aug 08, 2024
A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study.

Manar A Serageldin, Noha A El-Bassiouny, Yasser El-Kerm

Pageof 2

Frequent Collaborators

2 joint publications

Manar A Serageldin

2 joint publications

Amira B Kassem

2 joint publications

Mahmoud M El-Mas

2 joint publications

Noha A El-Bassiouny